NCT05062668

Efficacy and Safety of iStent Inject and Inject W in the Management of Primary Open-angle Glaucoma

RecruitingOBSERVATIONAL

Trial Details

Start: 2021-09-20Est. Completion: 2026-06

Enrollment target: 100 participants

Locations

Contact

Primary Open Angle Glaucoma

Glaucoma is the second most common cause of blindness in the world, second only to cataracts. This study will assess how…

Glendale, United StatesEst. completion Nov 2028

Open Angle Glaucoma (OAG)Primary Open Angle Glaucoma (POAG)Secondary Open Angle Glaucoma

The goal of this study is to determine of one of three different devices to perform goniotomy to treat glaucoma at the t…

Detroit, United StatesEst. completion Mar 1, 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.